Literature DB >> 20739391

p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway.

Lin Sun1, Li Xiao, Jing Nie, Fu-You Liu, Guang-Hui Ling, Xue-Jing Zhu, Wen-Bin Tang, Wen-Cui Chen, Yun-Cheng Xia, Ming Zhan, Ming-Ming Ma, You-Ming Peng, Hong Liu, Ying-Hong Liu, Yashpal S Kanwar.   

Abstract

p66Shc, a promoter of apoptosis, modulates oxidative stress response and cellular survival, but its role in the progression of diabetic nephropathy is relatively unknown. In this study, mechanisms by which p66Shc modulates high-glucose (HG)- or angiotensin (ANG) II-induced mitochondrial dysfunction were investigated in renal proximal tubular cells (HK-2 cells). Expression of p66Shc and its phosphorylated form (p-p66Shc, serine residue 36) and apoptosis were notably increased in renal tubules of diabetic mice, suggesting an increased reactive oxygen species production. In vitro, HG and ANG II led to an increased expression of total and p-p66Shc in HK-2 cells. These changes were accompanied with increased production of mitochondrial H(2)O(2), reduced mitochondrial membrane potential, increased translocation of mitochondrial cytochrome c from mitochondria into cytosol, upregulation of the expression of caspase-9, and ultimately reduced cell survival. Overexpression of a dominant-negative Ser36 mutant p66Shc (p66ShcS36A) or treatment of p66Shc- or PKC-β-short interfering RNAs partially reversed these changes. Treatment of HK-2 cells with HG and ANG II also increased the protein-protein association between p-p66Shc and Pin1, an isomerase, in the cytosol, and with cytochrome c in the mitochondria. These interactions were partially disrupted with the treatment of PKC-β inhibitor or Pin1-short interfering RNA. These data suggest that p66Shc mediates HG- and ANG II-induced mitochondrial dysfunctions via PKC-β and Pin1-dependent pathways in renal tubular cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739391      PMCID: PMC2980400          DOI: 10.1152/ajprenal.00414.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  39 in total

Review 1.  Update on mechanisms of ischemic acute kidney injury.

Authors:  Prasad Devarajan
Journal:  J Am Soc Nephrol       Date:  2006-05-17       Impact factor: 10.121

2.  Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.

Authors:  Stefano Menini; Lorena Amadio; Giovanna Oddi; Carlo Ricci; Carlo Pesce; Francesco Pugliese; Marco Giorgio; Enrica Migliaccio; PierGiuseppe Pelicci; Carla Iacobini; Giuseppe Pugliese
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

Review 3.  Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.

Authors:  Hunjoo Ha; Hi Bahl Lee
Journal:  Nephrology (Carlton)       Date:  2005-10       Impact factor: 2.506

4.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

Authors:  Katalin Susztak; Amanda C Raff; Mario Schiffer; Erwin P Böttinger
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

Review 5.  The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction.

Authors:  Andrew M Hall; Robert J Unwin
Journal:  Nephron Physiol       Date:  2006-11-08

6.  Apoptosis in the kidneys of patients with type II diabetic nephropathy.

Authors:  D Verzola; M T Gandolfo; F Ferrario; M P Rastaldi; B Villaggio; F Gianiorio; M Giannoni; L Rimoldi; F Lauria; M Miji; G Deferrari; G Garibotto
Journal:  Kidney Int       Date:  2007-09-12       Impact factor: 10.612

7.  Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.

Authors:  Lin Sun; Shetha Shukair; Tejaswitha Jairaj Naik; Farzad Moazed; Hossein Ardehali
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

8.  Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins.

Authors:  Sanae Haga; Keita Terui; Moto Fukai; Yuko Oikawa; Kaikobad Irani; Hiroyuki Furukawa; Satoru Todo; Michitaka Ozaki
Journal:  J Hepatol       Date:  2007-12-31       Impact factor: 25.083

9.  Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction.

Authors:  Lin Sun; Ping Xie; Jun Wada; Naoki Kashihara; Fu-you Liu; Yanan Zhao; Deepak Kumar; Sumant S Chugh; Farhad R Danesh; Yashpal S Kanwar
Journal:  J Am Soc Nephrol       Date:  2008-08-27       Impact factor: 10.121

10.  Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc.

Authors:  Paolo Pinton; Alessandro Rimessi; Saverio Marchi; Francesca Orsini; Enrica Migliaccio; Marco Giorgio; Cristina Contursi; Saverio Minucci; Fiamma Mantovani; Mariusz R Wieckowski; Giannino Del Sal; Pier Giuseppe Pelicci; Rosario Rizzuto
Journal:  Science       Date:  2007-02-02       Impact factor: 47.728

View more
  45 in total

Review 1.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

Review 2.  Cytochrome c: the Achilles' heel in apoptosis.

Authors:  A V Kulikov; E S Shilov; I A Mufazalov; V Gogvadze; S A Nedospasov; B Zhivotovsky
Journal:  Cell Mol Life Sci       Date:  2011-12-17       Impact factor: 9.261

3.  The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells.

Authors:  Annalisa Natalicchio; Federica Tortosa; Rossella Labarbuta; Giuseppina Biondi; Nicola Marrano; Emanuele Carchia; Anna Leonardini; Angelo Cignarelli; Marco Bugliani; Piero Marchetti; Gian Paolo Fadini; Marco Giorgio; Angelo Avogaro; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2015-03-26       Impact factor: 10.122

Review 4.  Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

5.  Deletion of p66Shc in mice increases the frequency of size-change mutations in the lacZ transgene.

Authors:  Elena Beltrami; Antonella Ruggiero; Rita Busuttil; Enrica Migliaccio; Pier Giuseppe Pelicci; Jan Vijg; Marco Giorgio
Journal:  Aging Cell       Date:  2013-01-10       Impact factor: 9.304

6.  Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Authors:  Sergi Clotet; Maria Jose Soler; Marta Riera; Julio Pascual; Fei Fang; Joyce Zhou; Ihor Batruch; Stella K Vasiliou; Apostolos Dimitromanolakis; Clara Barrios; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

7.  Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.

Authors:  Bradley S Miller; Shoshana R Blumenthal; Alexey Shalygin; Kevin D Wright; Alexander Staruschenko; John D Imig; Andrey Sorokin
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

8.  Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells.

Authors:  Jin Oshikawa; Seok-Jo Kim; Eiji Furuta; Cristiana Caliceti; Gin-Fu Chen; Ronald D McKinney; Frank Kuhr; Irena Levitan; Tohru Fukai; Masuko Ushio-Fukai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

Review 9.  Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.

Authors:  Francesco Paneni; Sarah Costantino; Francesco Cosentino
Journal:  Cardiovasc Diagn Ther       Date:  2014-08

Review 10.  Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease.

Authors:  Peng Gao; Wenxia Yang; Lin Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.